share_log

US Bancorp DE Lowers Position in Balchem Co. (NASDAQ:BCPC)

US Bancorp DE Lowers Position in Balchem Co. (NASDAQ:BCPC)

US Bancorp DE下调在Balchem Co.的地位(纳斯达克股票代码:BCPC)
Defense World ·  2022/09/02 07:11

US Bancorp DE cut its holdings in shares of Balchem Co. (NASDAQ:BCPC – Get Rating) by 2.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,727 shares of the basic materials company's stock after selling 408 shares during the quarter. US Bancorp DE owned about 0.06% of Balchem worth $2,560,000 as of its most recent filing with the Securities and Exchange Commission.

据Balchem Co.最近提交给美国证券交易委员会的文件显示,US Bancorp DE第一季度将其持有的Balchem Co.股票减持了2.1%。该公司在本季度出售了408股后,持有这家基础材料公司18,727股股票。截至最近提交给美国证券交易委员会(Securities And Exchange Commission)的文件,US Bancorp DE拥有Balchem约0.06%的股份,价值256万美元。

A number of other hedge funds have also modified their holdings of BCPC. Advisor Group Holdings Inc. grew its holdings in shares of Balchem by 4.2% during the 4th quarter. Advisor Group Holdings Inc. now owns 5,264 shares of the basic materials company's stock worth $887,000 after purchasing an additional 211 shares during the period. American Century Companies Inc. purchased a new position in Balchem during the 4th quarter valued at about $671,000. First Trust Advisors LP boosted its holdings in Balchem by 87.4% during the 4th quarter. First Trust Advisors LP now owns 63,774 shares of the basic materials company's stock valued at $10,752,000 after acquiring an additional 29,749 shares during the period. CIBC Asset Management Inc purchased a new position in Balchem during the 4th quarter valued at about $213,000. Finally, Raymond James & Associates boosted its holdings in Balchem by 1.1% during the 4th quarter. Raymond James & Associates now owns 38,228 shares of the basic materials company's stock valued at $6,445,000 after acquiring an additional 422 shares during the period. 89.15% of the stock is currently owned by hedge funds and other institutional investors.

其他一些对冲基金也调整了对BCPC的持股。Advisor Group Holdings Inc.在第四季度增持了4.2%的Balchem股票。Advisor Group Holdings Inc.在此期间又购买了211股,目前持有这家基础材料公司5,264股股票,价值88.7万美元。美国世纪公司在第四季度购买了Balchem的一个新头寸,价值约67.1万美元。First Trust Advisors LP在第四季度增持了87.4%的Balchem股份。First Trust Advisors LP现在拥有这家基础材料公司的63,774股股票,价值10,752,000美元,在此期间又购买了29,749股。加拿大帝国商业银行资产管理公司在第四季度购买了Balchem的一个新头寸,价值约21.3万美元。最后,Raymond James&Associates在第四季度将其在Balchem的持股增加了1.1%。Raymond James&Associates在此期间增持了422股,现在拥有这家基础材料公司38,228股股票,价值6,445,000美元。89.15%的股票目前由对冲基金和其他机构投资者持有。

Get
到达
Balchem
巴尔切姆
alerts:
警报:

Balchem Price Performance

Balchem性价比

BCPC stock opened at $130.43 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.62 and a quick ratio of 1.64. The firm has a market capitalization of $4.19 billion, a P/E ratio of 39.05 and a beta of 0.59. The business's 50-day moving average is $131.41 and its two-hundred day moving average is $130.21. Balchem Co. has a 1 year low of $110.15 and a 1 year high of $174.29.

上周五,北京石化股价开盘报130.43美元。该公司的债务权益比为0.50,流动比率为2.62,速动比率为1.64。该公司的市值为41.9亿美元,市盈率为39.05倍,贝塔系数为0.59。该业务的50日移动均线切入位在131.41美元,200日移动均线切入位在130.21美元。Balchem Co.的一年低点为110.15美元,一年高位为174.29美元。

Insider Buying and Selling at Balchem

Balchem的内幕买卖

In other Balchem news, VP Gunsteren Job Leonard Van sold 1,000 shares of the stock in a transaction dated Friday, August 12th. The stock was sold at an average price of $131.12, for a total value of $131,120.00. Following the sale, the vice president now owns 1,430 shares of the company's stock, valued at approximately $187,501.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is owned by corporate insiders.
在Balchem的其他新闻中,副总裁冈斯特恩·约伯·伦纳德·范在8月12日星期五的交易中出售了1,000股该股。这只股票的平均售价为131.12美元,总价值为131,120.00美元。出售股份后,总裁副手现在持有该公司1430股股票,价值约为187,501.60美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过美国证券交易委员会网站获得。1.60%的股份由企业内部人士持有。

Wall Street Analysts Forecast Growth

华尔街分析师预测经济增长

A number of equities analysts recently commented on BCPC shares. StockNews.com cut Balchem from a "buy" rating to a "hold" rating in a report on Monday, August 1st. HC Wainwright increased their price target on Balchem from $152.00 to $164.00 and gave the company a "buy" rating in a research report on Monday, August 22nd.

一些股票分析师最近对BCPC的股票发表了评论。StockNews.com在8月1日周一的一份报告中将Balchem的评级从“买入”下调至“持有”。8月22日,周一,HC Wainwright在一份研究报告中将Balchem的目标价从152.00美元上调至164.00美元,并给予该公司“买入”评级。

Balchem Company Profile

Balchem公司简介

(Get Rating)

(获取评级)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Balchem公司为美国和国际的营养、食品、制药、动物保健、医疗器械消毒、植物营养和工业市场开发、制造和销售特殊性能成分和产品。它通过三个部分运作:人类营养与健康,动物营养与健康,以及特色产品。

Read More

阅读更多内容

  • Get a free copy of the StockNews.com research report on Balchem (BCPC)
  • Could Nike Stock be Oversold, but Still Overvalued?
  • Is Alcoa A Buy After Strong Q2 Results And More Share Buybacks?
  • Will Royal Caribbean's Broadband Partnership Drive Revenue?
  • Chip Gear Maker Entegris Has Potential, But Is It Buyable Now?
  • DocuSign Has Important Issues to Address When it Reports Earnings
  • 免费获取StockNews.com关于Balchem的研究报告(BCPC)
  • 耐克股票会被超卖,但仍被高估吗?
  • 美国铝业是在第二季度业绩强劲和更多股票回购之后买入的吗?
  • 皇家加勒比的宽带合作能否推动收入增长?
  • 芯片设备制造商Entigis很有潜力,但它现在可以买下吗?
  • DocuSign在报告收益时有重要的问题需要解决

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.

接受Balchem Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Balchem和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发